Bayer | BAYN - Net Income

Stock Price
36.62
Daily Change
-1.76 -4.59%
Monthly
-6.26%
Yearly
58.05%
Q2 Forecast
37.49

Bayer reported EUR-3.76B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Air Liquide EUR 1.72B 84.3M Dec/2025
Akzo Nobel EUR 93M 505M Mar/2026
Alcon AG USD 217M 20M Dec/2025
Amarin USD -1.22M 6.51M Dec/2025
Arkema EUR -92M 127M Dec/2025
AstraZeneca USD 2.33B 207M Dec/2025
BASF EUR 560M 388M Dec/2025
Bayer EUR -3.76B 2.79B Dec/2025
Beiersdorf EUR 387M 165M Dec/2025
Corteva USD -552M 232M Dec/2025
Covestro EUR -378M 331M Dec/2025
Essilor EUR 928M 459M Dec/2025
Fresenius EUR 361M 17M Dec/2025
Fresenius Medical Care EUR 327M 52.2M Dec/2025
Genmab DKK 31M 370M Dec/2025
Givaudan CHF 479M 113M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
GRIFOLS EUR 98.25M 28.72M Dec/2025
Henkel EUR 925M 185M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Johnson Matthey GBP -18M 93M Dec/2025
Linde USD 1.53B 399M Dec/2025
Lonza CHF 426M 119M Jun/2025
Merck EUR 319M 583M Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Nutrien USD 571M 107M Dec/2025
Philips EUR 395M 211M Dec/2025
PPG Industries USD 300M 153M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR 1.61B 2.42B Mar/2026
SAP EUR 1.93B 86M Mar/2026
Solvay EUR -95M 129M Dec/2025
UCB EUR 1.08B 608M Dec/2025
Umicore EUR 136.7M 140.65M Jun/2025
Vinci EUR 3.01B 1.11B Dec/2025